171 related articles for article (PubMed ID: 35610758)
1. Expression of PD-L1 on regulatory B cells in patients with acute myeloid leukaemia and its effect on prognosis.
Shi Y; Liu Z; Wang H
J Cell Mol Med; 2022 Jun; 26(12):3506-3512. PubMed ID: 35610758
[TBL] [Abstract][Full Text] [Related]
2. The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1
Li X; Du H; Zhan S; Liu W; Wang Z; Lan J; PuYang L; Wan Y; Qu Q; Wang S; Yang Y; Wang Q; Xie F
Front Immunol; 2022; 13():830606. PubMed ID: 35935985
[TBL] [Abstract][Full Text] [Related]
3. [The proportion of CD19
Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256
[TBL] [Abstract][Full Text] [Related]
4. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
Wang Z; Tan F
Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
[TBL] [Abstract][Full Text] [Related]
5. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.
Yang H; Bueso-Ramos C; DiNardo C; Estecio MR; Davanlou M; Geng QR; Fang Z; Nguyen M; Pierce S; Wei Y; Parmar S; Cortes J; Kantarjian H; Garcia-Manero G
Leukemia; 2014 Jun; 28(6):1280-8. PubMed ID: 24270737
[TBL] [Abstract][Full Text] [Related]
6. Increased PD-1 expression of bone marrow T-cells in acute myeloid leukaemia patients after stem cell transplantation, and its association with overall survival.
You E; Park CJ; Cho YU; Jang S; Lee MY; Kim H; Koh KN; Im HJ; Choi EJ; Lee JH; Lee KH
Ann Clin Biochem; 2024 Mar; 61(2):79-89. PubMed ID: 37314798
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
[TBL] [Abstract][Full Text] [Related]
8. PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia.
Gamaleldin MA; Ghallab OM; Nadwan EA; Abo Elwafa RA
Clin Transl Oncol; 2021 Nov; 23(11):2309-2322. PubMed ID: 34120295
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of immune checkpoints in acute myeloid leukemia.
Chen C; Liang C; Wang S; Chio CL; Zhang Y; Zeng C; Chen S; Wang C; Li Y
J Hematol Oncol; 2020 Apr; 13(1):28. PubMed ID: 32245463
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.
Wang F; Yang L; Xiao M; Zhang Z; Shen J; Anuchapreeda S; Tima S; Chiampanichayakul S; Xiao Z
Sci Rep; 2022 Jul; 12(1):11444. PubMed ID: 35794161
[TBL] [Abstract][Full Text] [Related]
11. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
[TBL] [Abstract][Full Text] [Related]
12. PD-1/PD-L1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia.
Soltani M; Vosoughi M; Ganjalikhani-Hakemi M; Shapoorian H; Beshkar P; Eskandari N; Ghezelbash B
Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):495-503. PubMed ID: 38085150
[TBL] [Abstract][Full Text] [Related]
13. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
14. THE ROLE GENE EXPRESSION OF PD-1 AND PD-L1 IN NEWELY DIAGNOSED AND TREATED PATIENTS WITH ACUTE MYELOID LEUKEMIA.
Al-Saedi S; Hamzah I
Georgian Med News; 2023; (340-341):25-29. PubMed ID: 37805869
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of immune checkpoint programmed cell death protein-1 (PD-1) on T cell subsets of bone marrow aspirates in patients with B-Lymphoblastic leukemia, especially in relapse and at diagnosis.
Park SH; You E; Park CJ; Cho YU; Jang S; Im HJ; Seo JJ; Park HS; Lee JH
Cytometry B Clin Cytom; 2020 Jul; 98(4):336-347. PubMed ID: 32268011
[TBL] [Abstract][Full Text] [Related]
16. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.
Guan H; Wan Y; Lan J; Wang Q; Wang Z; Li Y; Zheng J; Zhang X; Wang Z; Shen Y; Xie F
Sci Rep; 2016 Oct; 6():35651. PubMed ID: 27762298
[TBL] [Abstract][Full Text] [Related]
18. Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia.
Dong Q; Li G; Fozza C; Wang S; Yang S; Sang Y; Liu X; Chen C
Biomed Res Int; 2020; 2020():7023168. PubMed ID: 33083479
[TBL] [Abstract][Full Text] [Related]
19. [Expression and Significance of PD-L1, HSP90 and HSP90α in Serum of Patients with Acute Leukemia].
Ma XJ; Zhang FH; Sun L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1384-1389. PubMed ID: 29070112
[TBL] [Abstract][Full Text] [Related]
20. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
